Lin Liwei Lorraine bought NBP
July 8, 2026 · Form 4 insider transaction
Lin Liwei Lorraine bought 254,780 shares of NovaBridge Biosciences at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
254,780
Price
$0.00
Total value
N/A
InsiderLin Liwei Lorraine
RoleOfficer
CompanyNovaBridge Biosciences (NBP)
Security2025 Employee Share Option (right to buy)
Transaction codeA: Grant or award
Transaction dateJuly 8, 2026
Filing dateJuly 10, 2026
Shares owned after254,780
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Number of underlying securities and exercise price expressed in terms of American Depositary Shares ("ADS").; The option vests and becomes exercisable over five years, with 40% vesting on the second anniversary of February 1, 2026 and the balance vesting in three equal annual installments thereafter.; The Ordinary Shares may be represented by ADSs. Each 10 ADSs represent 23 Ordinary Shares of the Issuer.